Xueran Kang

555 total citations
20 papers, 405 citations indexed

About

Xueran Kang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xueran Kang has authored 20 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Xueran Kang's work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Cancer-related molecular mechanisms research (3 papers). Xueran Kang is often cited by papers focused on MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Cancer-related molecular mechanisms research (3 papers). Xueran Kang collaborates with scholars based in China, United States and Japan. Xueran Kang's co-authors include Yisheng Chen, Chenting Ying, Jie Tao, Yang Jiang, Zhijie Zhao, Weiwei Lin, Bao Sun, Beijie Qi, Yunpeng Zhang and Zhiwen Luo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Pharmacology and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Xueran Kang

20 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueran Kang China 12 201 117 73 68 53 20 405
Shinya Osone Japan 11 187 0.9× 74 0.6× 46 0.6× 76 1.1× 28 0.5× 37 402
Yuhu He China 11 147 0.7× 59 0.5× 112 1.5× 37 0.5× 50 0.9× 16 425
Hanxi Wan China 9 166 0.8× 74 0.6× 139 1.9× 37 0.5× 27 0.5× 13 409
Guohua Zhao China 9 152 0.8× 63 0.5× 67 0.9× 180 2.6× 101 1.9× 20 505
Junteng Zhou China 12 268 1.3× 57 0.5× 31 0.4× 50 0.7× 51 1.0× 24 471
Sarah Franco United States 8 307 1.5× 75 0.6× 75 1.0× 44 0.6× 49 0.9× 13 444
Takatoshi Uchida Japan 12 198 1.0× 50 0.4× 148 2.0× 42 0.6× 49 0.9× 17 413
Zongqi Zhang China 10 261 1.3× 130 1.1× 40 0.5× 27 0.4× 42 0.8× 22 449
Chuanxi Yang China 13 228 1.1× 86 0.7× 38 0.5× 47 0.7× 39 0.7× 28 422
Chuyan Wu China 14 212 1.1× 144 1.2× 115 1.6× 63 0.9× 20 0.4× 55 479

Countries citing papers authored by Xueran Kang

Since Specialization
Citations

This map shows the geographic impact of Xueran Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueran Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueran Kang more than expected).

Fields of papers citing papers by Xueran Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueran Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueran Kang. The network helps show where Xueran Kang may publish in the future.

Co-authorship network of co-authors of Xueran Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Xueran Kang. A scholar is included among the top collaborators of Xueran Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueran Kang. Xueran Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yisheng, Xiaofeng Chen, Zhiwen Luo, et al.. (2024). Exercise-Induced Reduction of IGF1R Sumoylation Attenuates Neuroinflammation in APP/PS1 Transgenic Mice. Journal of Advanced Research. 69. 279–297. 27 indexed citations
3.
Chen, Yisheng, Zhiwen Luo, Xueran Kang, et al.. (2024). Impacts of Nutlin-3a and exercise on murine double minute 2–enriched glioma treatment. Neural Regeneration Research. 20(4). 1135–1152. 4 indexed citations
4.
Chen, Bin, Xueran Kang, Chenyan Jiang, et al.. (2022). Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes. Frontiers in Genetics. 13. 981222–981222. 8 indexed citations
5.
Chen, Yisheng, Zhiwen Luo, Yaying Sun, et al.. (2022). The effect of denture-wearing on physical activity is associated with cognitive impairment in the elderly: A cross-sectional study based on the CHARLS database. Frontiers in Neuroscience. 16. 925398–925398. 8 indexed citations
6.
Chen, Yisheng, Zhiwen Luo, Yaying Sun, et al.. (2022). Exercise improves choroid plexus epithelial cells metabolism to prevent glial cell-associated neurodegeneration. Frontiers in Pharmacology. 13. 1010785–1010785. 27 indexed citations
7.
Lin, Weiwei, Qian Wang, Zhihua Han, et al.. (2022). Quercetin targets VCAM1 to prevent diabetic cerebrovascular endothelial cell injury. Frontiers in Aging Neuroscience. 14. 944195–944195. 12 indexed citations
9.
Chen, Yisheng, Yaying Sun, Zhiwen Luo, et al.. (2022). Potential Mechanism Underlying Exercise Upregulated Circulating Blood Exosome miR-215-5p to Prevent Necroptosis of Neuronal Cells and a Model for Early Diagnosis of Alzheimer’s Disease. Frontiers in Aging Neuroscience. 14. 860364–860364. 39 indexed citations
10.
Kang, Xueran, et al.. (2022). Potential mechanism of the Shunaoxin pill for preventing cognitive impairment in type 2 diabetes mellitus. Frontiers in Neurology. 13. 977953–977953. 3 indexed citations
12.
Kang, Xueran, Bin Yi, Chenyan Jiang, et al.. (2022). Exploring the Mechanism of Yiqi Qingre Ziyin Method in Regulating Neuropeptide Expression for the Treatment of Atrophic Rhinitis. Disease Markers. 2022. 1–12. 10 indexed citations
13.
Li, Yue, et al.. (2022). Prognostic and Functional Analysis of NPY6R in Uveal Melanoma Using Bioinformatics. Disease Markers. 2022. 1–14. 9 indexed citations
14.
Zhao, Zhijie, Tongqi Li, Xiaohua Dong, et al.. (2021). Untargeted Metabolomic Profiling of Cuprizone‐Induced Demyelination in Mouse Corpus Callosum by UPLC‐Orbitrap/MS Reveals Potential Metabolic Biomarkers of CNS Demyelination Disorders. Oxidative Medicine and Cellular Longevity. 2021(1). 7093844–7093844. 38 indexed citations
15.
16.
Kang, Xueran, Bin Chen, Yisheng Chen, et al.. (2020). A prediction modeling based on SNOT-22 score for endoscopic nasal septoplasty: a retrospective study. PeerJ. 8. e9890–e9890. 19 indexed citations
17.
Chen, Yisheng, Xueran Kang, Zihui Zhou, et al.. (2020). Predicting the risk of sarcopenia in elderly patients with patellar fracture: development and assessment of a new predictive nomogram. PeerJ. 8. e8793–e8793. 16 indexed citations
18.
Wang, Yao, Zhijie Zhao, Xueran Kang, et al.. (2020). lncRNA DLEU2 acts as a miR-181a sponge to regulate SEPP1 and inhibit skeletal muscle differentiation and regeneration. Aging. 12(23). 24033–24056. 72 indexed citations
19.
Chen, Yisheng, Xueran Kang, Zihui Zhou, et al.. (2020). MiR-1908/EXO1 and MiR-203a/FOS, regulated by scd1, are associated with fracture risk and bone health in postmenopausal diabetic women. Aging. 12(10). 9549–9584. 28 indexed citations
20.
Chen, Yisheng, Xueran Kang, Jie Tao, et al.. (2019). Reliability of synovial fluid alpha-defensin and leukocyte esterase in diagnosing periprosthetic joint infection (PJI): a systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research. 14(1). 453–453. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026